Trial Profile
Impact of Cannabidiol on Quality of Life in Pediatric Drug Resistant Epilepsy
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 03 Dec 2015 New trial record